Healthcare >> CEO Interviews >> May 10, 2004
MICHAEL KERINS is Chief Executive of Cytomyx Holdings Plc. He graduated
from Warwick University in 1991 with a BSc in Microbiology and Microbial
Technology. After graduation, he joined Cambridge BioScience where he
held a variety of sales and marketing positions. Mr. Kerins, who has
extensive experience marketing genomics-related products and services to
the academic and pharmaceutical sectors in the UK and internationally,
co-founded Cytomyx in 1996. He has led the company throughout its
development, including its listing on the London Stock Exchange's
Alternative Investment Market and several fund-raisings and
acquisitions. Profile
Mr. Kerins: Cytomyx is a life science company. It's one that is
developing a whole series of solutions that address the
